All Stories

  1. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial

    Article • Journal of the American Heart Association, June 2017, Wolters Kluwer Health

    Dr Eugene Braunwald

  2. A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial

    Article • European Heart Journal, January 2017, European Society of Cardiology

    Dr Eugene Braunwald

  3. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial

    Article • Clinical Chemistry, November 2016, AACC

    Petr Jarolím, Keith Fox, Dr Eugene Braunwald, David Morrow

  4. The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial

    Article • European Heart Journal, August 2016, European Society of Cardiology

    Dr Eugene Braunwald

  5. Reduction of LDL-cholesterol: important at all ages

    Article • European Heart Journal, March 2016, European Society of Cardiology

    Dr Eugene Braunwald

  6. Academic-industrial collaboration in the development of the first angiotensin receptor blocker: neprilysin inhibitor in the treatment of heart failure: Table 1

    Article • European Heart Journal, March 2016, European Society of Cardiology

    Dr Eugene Braunwald

  7. Responsiveness to loop diuretics in heart failure

    Article • European Heart Journal, March 2014, European Society of Cardiology

    Dr Eugene Braunwald

  8. Hypertrophic cardiomyopathy: The first century 1869–1969

    Article • Global Cardiology Science and Practice, July 2012, QScience

    Dr Eugene Braunwald